JP Morgan Chase
PJP icon

JP Morgan Chase’s Invesco Pharmaceuticals ETF PJP Stock Holding History

JP Morgan Chase’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$101K Hold
1,004
– – ﹤0.01% 5829
2025
Q4 		$105K Hold
1,004
– – ﹤0.01% 5859
2025
Q3 		$92.9K Sell
1,004
-182
-15% -$15.9K ﹤0.01% 5943
2025
Q2 		$94.7K Sell
1,186
-3,115
-72% -$249K ﹤0.01% 5630
2025
Q1 		$373K Hold
4,301
– – ﹤0.01% 4951
2024
Q4 		$355K Buy
4,301
+255
+6% +$21.9K ﹤0.01% 5214
2024
Q3 		$352K Buy
4,046
+2,862
+242% +$245K ﹤0.01% 5116
2024
Q2 		$97.3K Sell
1,184
-2,981
-72% -$237K ﹤0.01% 5531
2024
Q1 		$334K Hold
4,165
– – ﹤0.01% 5045
2023
Q4 		$317K Buy
4,165
+3,931
+1,680% +$281K ﹤0.01% 5074
2023
Q3 		$16.9K Sell
234
-21
-8% -$1.61K ﹤0.01% 6109
2023
Q2 		$19.3K Buy
+255
New +$19.5K ﹤0.01% 5925
2023
Q1 		– Sell
-4,669
Closed -$367K – 7111
2022
Q4 		$367K Buy
+4,669
New +$359K ﹤0.01% 4710
2022
Q2 		– Sell
-347
Closed -$28K – 6775
2022
Q1 		$28K Sell
347
-860
-71% -$66.7K ﹤0.01% 5995
2021
Q4 		$98K Buy
1,207
+137
+13% +$10.8K ﹤0.01% 5694
2021
Q3 		$83K Sell
1,070
-1,663
-61% -$134K ﹤0.01% 5664
2021
Q2 		$220K Buy
2,733
+1,761
+181% +$140K ﹤0.01% 5189
2021
Q1 		$77K Hold
972
– – ﹤0.01% 5446
2020
Q4 		$69K Sell
972
-223
-19% -$14.9K ﹤0.01% 5082
2020
Q3 		$76K Sell
1,195
-7,561
-86% -$494K ﹤0.01% 4820
2020
Q2 		$566K Sell
8,756
-892
-9% -$55.4K ﹤0.01% 3803
2020
Q1 		$531K Buy
9,648
+1,183
+14% +$72K ﹤0.01% 3787
2019
Q4 		$547K Sell
8,465
-2,564
-23% -$156K ﹤0.01% 4189
2019
Q3 		$625K Buy
11,029
+183
+2% +$10.5K ﹤0.01% 4073
2019
Q2 		$647K Buy
10,846
+746
+7% +$45.8K ﹤0.01% 4105
2019
Q1 		$658K Buy
10,100
+800
+9% +$52.6K ﹤0.01% 4051
2018
Q4 		$580K Buy
9,300
+4,251
+84% +$287K ﹤0.01% 4056
2018
Q3 		$371K Buy
5,049
+818
+19% +$58.7K ﹤0.01% 4422
2018
Q2 		$285K Sell
4,231
-38
-0.9% -$2.44K ﹤0.01% 4421
2018
Q1 		$266K Buy
4,269
+50
+1% +$3.29K ﹤0.01% 4267
2017
Q4 		$271K Buy
4,219
+200
+5% +$12.8K ﹤0.01% 4306
2017
Q3 		$261K Buy
4,019
+2,844
+242% +$180K ﹤0.01% 4029
2017
Q2 		$74K Sell
1,175
-3,599
-75% -$216K ﹤0.01% 4258
2017
Q1 		$281K Sell
4,774
-10,845
-69% -$634K ﹤0.01% 3949
2016
Q4 		$875K Buy
15,619
+7,407
+90% +$427K ﹤0.01% 3504
2016
Q3 		$506K Sell
8,212
-6,736
-45% -$441K ﹤0.01% 3397
2016
Q2 		$947K Buy
14,948
+2,886
+24% +$182K ﹤0.01% 3200
2016
Q1 		$725K Buy
12,062
+6,015
+99% +$368K ﹤0.01% 3205
2015
Q4 		$423K Hold
6,047
– – ﹤0.01% 3446
2015
Q3 		$401K Hold
6,047
– – ﹤0.01% 3506
2015
Q2 		$474K Hold
6,047
– – ﹤0.01% 3574
2015
Q1 		$462K Hold
6,047
– – ﹤0.01% 3567
2014
Q4 		$402K Buy
+6,047
New +$403K ﹤0.01% 3760

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's PJP Position: Q1 2026 in Review

JP Morgan Chase held its Invesco Pharmaceuticals ETF (PJP) position steady in Q1 2026 at 1,004 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #5829.

JP Morgan Chase first reported a position in PJP in Q4 2014 and has held it in 43 quarters since. The position peaked at $947K in Q2 2016. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • JP Morgan Chase held 1,004 shares of Invesco Pharmaceuticals ETF worth $101K as of Q1 2026.
  • JP Morgan Chase left its Invesco Pharmaceuticals ETF share count unchanged in Q1 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5829 holding.
  • JP Morgan Chase first reported a position in Invesco Pharmaceuticals ETF in Q4 2014 and has held it in 43 quarters since.
  • JP Morgan Chase's Invesco Pharmaceuticals ETF position peaked at $947K in Q2 2016.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.